P2RY12 and chronic kidney disease: Initial findings showed that when compared with a less potent P2Y12 inhibitor (P2Y12-I), potent P2Y12-Is were associated with lower risk for lethal sepsis in dialysis patients with ESKD.6 Whether this finding translates to patients with CKD who are not receiving dialysis is unclear.